nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.185	0.534	CrCtD
Fluoxymesterone—Progesterone—uterine cancer	0.161	0.466	CrCtD
Fluoxymesterone—ESR1—uterine cancer	0.127	1	CbGaD
Fluoxymesterone—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.044	0.195	CbGbCtD
Fluoxymesterone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0368	0.163	CbGbCtD
Fluoxymesterone—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0318	0.141	CbGbCtD
Fluoxymesterone—SHBG—Progesterone—uterine cancer	0.0291	0.129	CbGbCtD
Fluoxymesterone—AR—Progesterone—uterine cancer	0.0244	0.108	CbGbCtD
Fluoxymesterone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0234	0.104	CbGbCtD
Fluoxymesterone—ESR1—Progesterone—uterine cancer	0.0211	0.0932	CbGbCtD
Fluoxymesterone—NR3C1—Progesterone—uterine cancer	0.0155	0.0686	CbGbCtD
Fluoxymesterone—Stanozolol—Progesterone—uterine cancer	0.0127	0.0539	CrCrCtD
Fluoxymesterone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.0126	0.0534	CrCrCtD
Fluoxymesterone—Eplerenone—Progesterone—uterine cancer	0.011	0.0466	CrCrCtD
Fluoxymesterone—Oxandrolone—Progesterone—uterine cancer	0.0103	0.0437	CrCrCtD
Fluoxymesterone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.01	0.0424	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.00955	0.0404	CrCrCtD
Fluoxymesterone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.00955	0.0404	CrCrCtD
Fluoxymesterone—Dydrogesterone—Progesterone—uterine cancer	0.00874	0.037	CrCrCtD
Fluoxymesterone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.00874	0.037	CrCrCtD
Fluoxymesterone—Spironolactone—Progesterone—uterine cancer	0.00833	0.0352	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Progesterone—uterine cancer	0.00833	0.0352	CrCrCtD
Fluoxymesterone—Megestrol acetate—Progesterone—uterine cancer	0.00762	0.0322	CrCrCtD
Fluoxymesterone—Danazol—Progesterone—uterine cancer	0.00703	0.0298	CrCrCtD
Fluoxymesterone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.00702	0.0297	CrCrCtD
Fluoxymesterone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0068	0.0288	CrCrCtD
Fluoxymesterone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00678	0.0287	CrCrCtD
Fluoxymesterone—Hydrocortamate—Progesterone—uterine cancer	0.00612	0.0259	CrCrCtD
Fluoxymesterone—Norethindrone—Progesterone—uterine cancer	0.00612	0.0259	CrCrCtD
Fluoxymesterone—Cortisone acetate—Progesterone—uterine cancer	0.00593	0.0251	CrCrCtD
Fluoxymesterone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00591	0.025	CrCrCtD
Fluoxymesterone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.00591	0.025	CrCrCtD
Fluoxymesterone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.00591	0.025	CrCrCtD
Fluoxymesterone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.00576	0.0244	CrCrCtD
Fluoxymesterone—Testolactone—Progesterone—uterine cancer	0.00575	0.0243	CrCrCtD
Fluoxymesterone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.00549	0.0232	CrCrCtD
Fluoxymesterone—Fludrocortisone—Progesterone—uterine cancer	0.00515	0.0218	CrCrCtD
Fluoxymesterone—Testosterone Propionate—Progesterone—uterine cancer	0.00515	0.0218	CrCrCtD
Fluoxymesterone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.0217	CrCrCtD
Fluoxymesterone—Methyltestosterone—Progesterone—uterine cancer	0.00502	0.0212	CrCrCtD
Fluoxymesterone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00482	0.0204	CrCrCtD
Fluoxymesterone—Testosterone—Progesterone—uterine cancer	0.00447	0.0189	CrCrCtD
Fluoxymesterone—Prednisolone—Progesterone—uterine cancer	0.00438	0.0185	CrCrCtD
Fluoxymesterone—Hydrocortisone—Progesterone—uterine cancer	0.0042	0.0178	CrCrCtD
Fluoxymesterone—PRLR—myometrium—uterine cancer	0.00202	0.0895	CbGeAlD
Fluoxymesterone—SHBG—semen—uterine cancer	0.00185	0.0823	CbGeAlD
Fluoxymesterone—PRLR—uterine cervix—uterine cancer	0.00157	0.0696	CbGeAlD
Fluoxymesterone—PRLR—decidua—uterine cancer	0.00149	0.0663	CbGeAlD
Fluoxymesterone—PRLR—endometrium—uterine cancer	0.00142	0.063	CbGeAlD
Fluoxymesterone—AR—semen—uterine cancer	0.00133	0.0591	CbGeAlD
Fluoxymesterone—PRLR—uterus—uterine cancer	0.00131	0.058	CbGeAlD
Fluoxymesterone—Clotting—Progesterone—uterine cancer	0.00123	0.0659	CcSEcCtD
Fluoxymesterone—Clotting—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.0597	CcSEcCtD
Fluoxymesterone—PRLR—female gonad—uterine cancer	0.00107	0.0475	CbGeAlD
Fluoxymesterone—AR—oviduct—uterine cancer	0.000976	0.0433	CbGeAlD
Fluoxymesterone—ESR1—oviduct—uterine cancer	0.000958	0.0425	CbGeAlD
Fluoxymesterone—Menstruation irregular—Progesterone—uterine cancer	0.000792	0.0425	CcSEcCtD
Fluoxymesterone—Hirsutism—Progesterone—uterine cancer	0.000755	0.0405	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.000718	0.0385	CcSEcCtD
Fluoxymesterone—Hirsutism—Medroxyprogesterone Acetate—uterine cancer	0.000684	0.0367	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Progesterone—uterine cancer	0.000643	0.0345	CcSEcCtD
Fluoxymesterone—Oligospermia—Epirubicin—uterine cancer	0.0006	0.0322	CcSEcCtD
Fluoxymesterone—Coagulopathy—Progesterone—uterine cancer	0.000563	0.0302	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—uterine cancer	0.000555	0.0298	CcSEcCtD
Fluoxymesterone—Coagulopathy—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.0274	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Progesterone—uterine cancer	0.000499	0.0268	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Progesterone—uterine cancer	0.000499	0.0268	CcSEcCtD
Fluoxymesterone—Azoospermia—Epirubicin—uterine cancer	0.000467	0.025	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.000452	0.0243	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000452	0.0243	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—uterine cancer	0.000432	0.0232	CcSEcCtD
Fluoxymesterone—Coagulopathy—Dactinomycin—uterine cancer	0.000398	0.0214	CcSEcCtD
Fluoxymesterone—Libido decreased—Progesterone—uterine cancer	0.000343	0.0184	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Progesterone—uterine cancer	0.000329	0.0176	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Progesterone—uterine cancer	0.000316	0.0169	CcSEcCtD
Fluoxymesterone—AR—myometrium—uterine cancer	0.000312	0.0139	CbGeAlD
Fluoxymesterone—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.0167	CcSEcCtD
Fluoxymesterone—ESR1—myometrium—uterine cancer	0.000307	0.0136	CbGeAlD
Fluoxymesterone—SHBG—endometrium—uterine cancer	0.000306	0.0136	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.000298	0.016	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.0154	CcSEcCtD
Fluoxymesterone—SHBG—uterus—uterine cancer	0.000282	0.0125	CbGeAlD
Fluoxymesterone—SHBG—female reproductive system—uterine cancer	0.000254	0.0113	CbGeAlD
Fluoxymesterone—AR—epithelium—uterine cancer	0.000245	0.0109	CbGeAlD
Fluoxymesterone—AR—uterine cervix—uterine cancer	0.000243	0.0108	CbGeAlD
Fluoxymesterone—ESR1—epithelium—uterine cancer	0.000241	0.0107	CbGeAlD
Fluoxymesterone—ESR1—uterine cervix—uterine cancer	0.000239	0.0106	CbGeAlD
Fluoxymesterone—AR—smooth muscle tissue—uterine cancer	0.000236	0.0105	CbGeAlD
Fluoxymesterone—ESR1—smooth muscle tissue—uterine cancer	0.000232	0.0103	CbGeAlD
Fluoxymesterone—AR—decidua—uterine cancer	0.000232	0.0103	CbGeAlD
Fluoxymesterone—SHBG—female gonad—uterine cancer	0.000231	0.0102	CbGeAlD
Fluoxymesterone—SHBG—vagina—uterine cancer	0.000229	0.0102	CbGeAlD
Fluoxymesterone—AR—renal system—uterine cancer	0.000227	0.0101	CbGeAlD
Fluoxymesterone—ESR1—decidua—uterine cancer	0.000227	0.0101	CbGeAlD
Fluoxymesterone—NR3C1—myometrium—uterine cancer	0.000226	0.01	CbGeAlD
Fluoxymesterone—ESR1—renal system—uterine cancer	0.000223	0.00991	CbGeAlD
Fluoxymesterone—Haemoglobin—Progesterone—uterine cancer	0.000221	0.0119	CcSEcCtD
Fluoxymesterone—Haemorrhage—Progesterone—uterine cancer	0.00022	0.0118	CcSEcCtD
Fluoxymesterone—AR—endometrium—uterine cancer	0.00022	0.00976	CbGeAlD
Fluoxymesterone—ESR1—endometrium—uterine cancer	0.000216	0.00958	CbGeAlD
Fluoxymesterone—AR—mammalian vulva—uterine cancer	0.000213	0.00944	CbGeAlD
Fluoxymesterone—AR—uterus—uterine cancer	0.000203	0.00899	CbGeAlD
Fluoxymesterone—Dydrogesterone—PGR—uterine cancer	0.000202	0.13	CrCbGaD
Fluoxymesterone—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000201	0.0108	CcSEcCtD
Fluoxymesterone—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.0002	0.0107	CcSEcCtD
Fluoxymesterone—ESR1—uterus—uterine cancer	0.000199	0.00883	CbGeAlD
Fluoxymesterone—Alopecia—Progesterone—uterine cancer	0.000195	0.0104	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—uterine cancer	0.000185	0.0099	CcSEcCtD
Fluoxymesterone—AR—female reproductive system—uterine cancer	0.000182	0.00808	CbGeAlD
Fluoxymesterone—ESR1—female reproductive system—uterine cancer	0.000179	0.00794	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—uterine cancer	0.000178	0.00788	CbGeAlD
Fluoxymesterone—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000176	0.00946	CcSEcCtD
Fluoxymesterone—NR3C1—uterine cervix—uterine cancer	0.000176	0.00781	CbGeAlD
Fluoxymesterone—NR3C1—smooth muscle tissue—uterine cancer	0.000171	0.00759	CbGeAlD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—uterine cancer	0.000171	0.00916	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—uterine cancer	0.000168	0.00903	CcSEcCtD
Fluoxymesterone—NR3C1—decidua—uterine cancer	0.000168	0.00745	CbGeAlD
Fluoxymesterone—AR—female gonad—uterine cancer	0.000166	0.00736	CbGeAlD
Fluoxymesterone—AR—vagina—uterine cancer	0.000165	0.00731	CbGeAlD
Fluoxymesterone—NR3C1—renal system—uterine cancer	0.000165	0.00731	CbGeAlD
Fluoxymesterone—Anxiety—Progesterone—uterine cancer	0.000163	0.00873	CcSEcCtD
Fluoxymesterone—ESR1—female gonad—uterine cancer	0.000163	0.00722	CbGeAlD
Fluoxymesterone—ESR1—vagina—uterine cancer	0.000162	0.00718	CbGeAlD
Fluoxymesterone—NR3C1—endometrium—uterine cancer	0.000159	0.00707	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Progesterone—uterine cancer	0.000156	0.00839	CcSEcCtD
Fluoxymesterone—NR3C1—mammalian vulva—uterine cancer	0.000154	0.00684	CbGeAlD
Fluoxymesterone—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000147	0.00791	CcSEcCtD
Fluoxymesterone—NR3C1—uterus—uterine cancer	0.000147	0.00651	CbGeAlD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—uterine cancer	0.000143	0.00768	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Epirubicin—uterine cancer	0.000143	0.00768	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000142	0.00761	CcSEcCtD
Fluoxymesterone—Paraesthesia—Progesterone—uterine cancer	0.000141	0.00754	CcSEcCtD
Fluoxymesterone—Alopecia—Dactinomycin—uterine cancer	0.000138	0.00738	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—uterine cancer	0.000132	0.0071	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000132	0.0071	CcSEcCtD
Fluoxymesterone—NR3C1—female reproductive system—uterine cancer	0.000132	0.00585	CbGeAlD
Fluoxymesterone—Danazol—CCL2—uterine cancer	0.000129	0.0836	CrCbGaD
Fluoxymesterone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000127	0.00683	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.000127	0.0823	CrCbGaD
Fluoxymesterone—Megestrol acetate—PGR—uterine cancer	0.000121	0.0785	CrCbGaD
Fluoxymesterone—NR3C1—female gonad—uterine cancer	0.00012	0.00533	CbGeAlD
Fluoxymesterone—NR3C1—vagina—uterine cancer	0.000119	0.0053	CbGeAlD
Fluoxymesterone—Hypersensitivity—Progesterone—uterine cancer	0.000115	0.00618	CcSEcCtD
Fluoxymesterone—Testolactone—CYP19A1—uterine cancer	0.000112	0.0726	CrCbGaD
Fluoxymesterone—AR—lymph node—uterine cancer	0.000107	0.00473	CbGeAlD
Fluoxymesterone—ESR1—lymph node—uterine cancer	0.000105	0.00464	CbGeAlD
Fluoxymesterone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000104	0.0056	CcSEcCtD
Fluoxymesterone—Alopecia—Etoposide—uterine cancer	9.96e-05	0.00534	CcSEcCtD
Fluoxymesterone—Headache—Progesterone—uterine cancer	9.8e-05	0.00526	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—uterine cancer	9.43e-05	0.00506	CcSEcCtD
Fluoxymesterone—Nausea—Progesterone—uterine cancer	9.3e-05	0.00499	CcSEcCtD
Fluoxymesterone—Headache—Medroxyprogesterone Acetate—uterine cancer	8.88e-05	0.00476	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—uterine cancer	8.73e-05	0.00468	CcSEcCtD
Fluoxymesterone—Nausea—Medroxyprogesterone Acetate—uterine cancer	8.42e-05	0.00452	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Dactinomycin—uterine cancer	8.15e-05	0.00437	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—uterine cancer	8.01e-05	0.00429	CcSEcCtD
Fluoxymesterone—Danazol—PGR—uterine cancer	7.87e-05	0.0509	CrCbGaD
Fluoxymesterone—NR3C1—lymph node—uterine cancer	7.71e-05	0.00342	CbGeAlD
Fluoxymesterone—Spironolactone—PGR—uterine cancer	7.54e-05	0.0488	CrCbGaD
Fluoxymesterone—Paraesthesia—Etoposide—uterine cancer	7.19e-05	0.00386	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—PGR—uterine cancer	7.06e-05	0.0457	CrCbGaD
Fluoxymesterone—Norethindrone—PGR—uterine cancer	7e-05	0.0453	CrCbGaD
Fluoxymesterone—Nausea—Dactinomycin—uterine cancer	6.57e-05	0.00352	CcSEcCtD
Fluoxymesterone—Betamethasone—PGR—uterine cancer	6.41e-05	0.0415	CrCbGaD
Fluoxymesterone—Haemoglobin—Epirubicin—uterine cancer	6.35e-05	0.00341	CcSEcCtD
Fluoxymesterone—Haemorrhage—Epirubicin—uterine cancer	6.32e-05	0.00339	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etoposide—uterine cancer	5.9e-05	0.00316	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—uterine cancer	5.87e-05	0.00315	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—uterine cancer	5.84e-05	0.00313	CcSEcCtD
Fluoxymesterone—Alopecia—Epirubicin—uterine cancer	5.58e-05	0.00299	CcSEcCtD
Fluoxymesterone—Danazol—CYP19A1—uterine cancer	5.4e-05	0.0349	CrCbGaD
Fluoxymesterone—Alopecia—Doxorubicin—uterine cancer	5.16e-05	0.00277	CcSEcCtD
Fluoxymesterone—Testosterone—CYP11A1—uterine cancer	5.12e-05	0.0331	CrCbGaD
Fluoxymesterone—Headache—Etoposide—uterine cancer	5.02e-05	0.00269	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—uterine cancer	4.97e-05	0.0322	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP11A1—uterine cancer	4.95e-05	0.032	CrCbGaD
Fluoxymesterone—Nausea—Etoposide—uterine cancer	4.76e-05	0.00255	CcSEcCtD
Fluoxymesterone—Anxiety—Epirubicin—uterine cancer	4.66e-05	0.0025	CcSEcCtD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	4.57e-05	0.0021	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—CYP19A1—uterine cancer	4.56e-05	0.0295	CrCbGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	4.51e-05	0.00207	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—uterine cancer	4.49e-05	0.00241	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	4.47e-05	0.00205	CbGpPWpGaD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—uterine cancer	4.46e-05	0.0289	CrCbGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	4.43e-05	0.00204	CbGpPWpGaD
Fluoxymesterone—Betamethasone—CYP19A1—uterine cancer	4.4e-05	0.0285	CrCbGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	4.34e-05	0.00199	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	4.32e-05	0.00198	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKR1C1—uterine cancer	4.32e-05	0.00198	CbGpPWpGaD
Fluoxymesterone—Anxiety—Doxorubicin—uterine cancer	4.32e-05	0.00232	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	4.19e-05	0.00192	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	4.19e-05	0.00192	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	4.18e-05	0.00192	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—uterine cancer	4.15e-05	0.00223	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	4.11e-05	0.00188	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	4.1e-05	0.00188	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	4.09e-05	0.00188	CbGpPWpGaD
Fluoxymesterone—Progesterone—PGR—uterine cancer	4.08e-05	0.0264	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.06e-05	0.00186	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	4.04e-05	0.00186	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	4.04e-05	0.00185	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Epirubicin—uterine cancer	4.03e-05	0.00216	CcSEcCtD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	3.99e-05	0.00183	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	3.99e-05	0.00183	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—KRAS—uterine cancer	3.94e-05	0.00181	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SOCS3—uterine cancer	3.92e-05	0.0018	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.89e-05	0.00179	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	3.79e-05	0.00174	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	3.77e-05	0.00173	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	3.77e-05	0.00173	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SOCS3—uterine cancer	3.75e-05	0.00172	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PGR—uterine cancer	3.73e-05	0.0242	CrCbGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—uterine cancer	3.73e-05	0.002	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	3.72e-05	0.00171	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.72e-05	0.00171	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.69e-05	0.00169	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.64e-05	0.00167	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.64e-05	0.00167	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	3.62e-05	0.00166	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	3.58e-05	0.00164	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	3.52e-05	0.00162	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	3.49e-05	0.0016	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	3.47e-05	0.00159	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.44e-05	0.00158	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	3.44e-05	0.00158	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SMAD3—uterine cancer	3.43e-05	0.00157	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	3.42e-05	0.00157	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PHF1—uterine cancer	3.42e-05	0.00157	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—uterine cancer	3.35e-05	0.00154	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKR1C3—uterine cancer	3.32e-05	0.00153	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—EP300—uterine cancer	3.32e-05	0.00153	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—uterine cancer	3.31e-05	0.00177	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.27e-05	0.0015	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	3.25e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	3.25e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	3.24e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PGR—uterine cancer	3.24e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	3.24e-05	0.00149	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	3.21e-05	0.00148	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	3.21e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	3.2e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	3.19e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	3.17e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	3.16e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.14e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.13e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGFR2—uterine cancer	3.13e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	3.13e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	3.12e-05	0.00143	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—YWHAE—uterine cancer	3.09e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—uterine cancer	3.06e-05	0.00164	CcSEcCtD
Fluoxymesterone—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	3.02e-05	0.00139	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	2.99e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	2.99e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EP300—uterine cancer	2.98e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FBXW7—uterine cancer	2.96e-05	0.00136	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	2.95e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—uterine cancer	2.94e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	2.93e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	2.92e-05	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	2.92e-05	0.00134	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CHD4—uterine cancer	2.91e-05	0.00134	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	2.87e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.85e-05	0.00131	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	2.82e-05	0.00129	CbGpPWpGaD
Fluoxymesterone—Headache—Epirubicin—uterine cancer	2.81e-05	0.00151	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.8e-05	0.00129	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EP300—uterine cancer	2.78e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	2.74e-05	0.00126	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.71e-05	0.00124	CbGpPWpGaD
Fluoxymesterone—Nausea—Epirubicin—uterine cancer	2.67e-05	0.00143	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.67e-05	0.00122	CbGpPWpGaD
Fluoxymesterone—Testosterone—CYP19A1—uterine cancer	2.65e-05	0.0171	CrCbGaD
Fluoxymesterone—ESR1—Gene Expression—PHF1—uterine cancer	2.64e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—Headache—Doxorubicin—uterine cancer	2.6e-05	0.0014	CcSEcCtD
Fluoxymesterone—NR3C1—Gene Expression—PHF1—uterine cancer	2.6e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STK11—uterine cancer	2.59e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	2.58e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—Progesterone—ESR1—uterine cancer	2.58e-05	0.0167	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP19A1—uterine cancer	2.56e-05	0.0166	CrCbGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PGR—uterine cancer	2.52e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.48e-05	0.00114	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—uterine cancer	2.47e-05	0.00132	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.44e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SUZ12—uterine cancer	2.44e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	2.44e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SOCS3—uterine cancer	2.43e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	2.42e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	2.4e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDH1—uterine cancer	2.33e-05	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN2B—uterine cancer	2.32e-05	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—uterine cancer	2.25e-05	0.00104	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CHD4—uterine cancer	2.24e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR2—uterine cancer	2.22e-05	0.00102	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.22e-05	0.00102	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CHD4—uterine cancer	2.21e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.19e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SMAD3—uterine cancer	2.12e-05	0.000973	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.1e-05	0.000965	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.05e-05	0.00094	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.05e-05	0.00094	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGFR2—uterine cancer	2.02e-05	0.000928	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—uterine cancer	1.99e-05	0.000914	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.99e-05	0.000914	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—uterine cancer	1.96e-05	0.000902	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	1.96e-05	0.000901	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.95e-05	0.000897	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PGR—uterine cancer	1.94e-05	0.000892	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.94e-05	0.000892	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	1.91e-05	0.000879	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	1.9e-05	0.000874	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SUZ12—uterine cancer	1.88e-05	0.000863	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SUZ12—uterine cancer	1.85e-05	0.000849	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.85e-05	0.000849	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.84e-05	0.000846	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	1.84e-05	0.000845	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1B—uterine cancer	1.82e-05	0.000835	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.81e-05	0.00083	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—uterine cancer	1.8e-05	0.000828	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.8e-05	0.000827	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	1.8e-05	0.000827	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	1.8e-05	0.000825	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.74e-05	0.000799	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—uterine cancer	1.73e-05	0.000794	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	1.73e-05	0.000793	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—uterine cancer	1.72e-05	0.00079	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—uterine cancer	1.72e-05	0.000789	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	1.71e-05	0.000785	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	1.7e-05	0.000783	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.7e-05	0.000779	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.68e-05	0.000774	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.68e-05	0.000773	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—uterine cancer	1.67e-05	0.000769	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.65e-05	0.000758	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.62e-05	0.000743	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.62e-05	0.000743	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EP300—uterine cancer	1.6e-05	0.000733	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—uterine cancer	1.59e-05	0.000731	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.58e-05	0.000724	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.57e-05	0.000722	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—uterine cancer	1.57e-05	0.000721	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.55e-05	0.000713	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.53e-05	0.000704	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.53e-05	0.000704	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—uterine cancer	1.52e-05	0.000699	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.5e-05	0.000691	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.5e-05	0.000687	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—uterine cancer	1.49e-05	0.000686	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.47e-05	0.000677	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.46e-05	0.00067	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.44e-05	0.000663	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.43e-05	0.000654	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.42e-05	0.000652	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—uterine cancer	1.4e-05	0.000643	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.4e-05	0.000642	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.39e-05	0.000639	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.37e-05	0.00063	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.37e-05	0.000628	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—uterine cancer	1.35e-05	0.000618	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.34e-05	0.000616	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.31e-05	0.0006	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.3e-05	0.000598	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—uterine cancer	1.29e-05	0.00059	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	1.27e-05	0.000584	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—uterine cancer	1.27e-05	0.000583	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.25e-05	0.000575	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.25e-05	0.000572	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PGR—uterine cancer	1.21e-05	0.000558	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.21e-05	0.000556	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—uterine cancer	1.21e-05	0.000553	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—uterine cancer	1.2e-05	0.000553	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.2e-05	0.00055	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1B10—uterine cancer	1.19e-05	0.000546	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—uterine cancer	1.18e-05	0.000542	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.18e-05	0.000542	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.18e-05	0.000542	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—uterine cancer	1.18e-05	0.00054	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.16e-05	0.000532	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—EZH2—uterine cancer	1.15e-05	0.00053	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—uterine cancer	1.11e-05	0.00051	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	1.11e-05	0.000508	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—uterine cancer	1.09e-05	0.000502	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—uterine cancer	1.08e-05	0.000497	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.08e-05	0.000494	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—uterine cancer	1.07e-05	0.000491	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—uterine cancer	1.03e-05	0.000474	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.02e-05	0.00047	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	1.02e-05	0.000469	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1e-05	0.000461	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RNF43—uterine cancer	9.85e-06	0.000452	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.78e-06	0.000449	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—uterine cancer	9.78e-06	0.000449	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—uterine cancer	9.66e-06	0.000443	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—uterine cancer	9.65e-06	0.000443	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PGR—uterine cancer	9.36e-06	0.00043	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.22e-06	0.000423	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PGR—uterine cancer	9.21e-06	0.000423	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	9.09e-06	0.000417	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—uterine cancer	9.05e-06	0.000415	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INHBA—uterine cancer	9.01e-06	0.000413	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.92e-06	0.00041	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—EZH2—uterine cancer	8.89e-06	0.000408	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—EZH2—uterine cancer	8.75e-06	0.000402	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—uterine cancer	8.7e-06	0.0004	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—uterine cancer	8.31e-06	0.000382	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—uterine cancer	8.24e-06	0.000378	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—uterine cancer	8.11e-06	0.000372	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C1—uterine cancer	8.11e-06	0.000372	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMAD3—uterine cancer	7.95e-06	0.000365	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—uterine cancer	7.64e-06	0.000351	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.53e-06	0.000346	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—uterine cancer	7.39e-06	0.000339	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—uterine cancer	7.07e-06	0.000324	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—uterine cancer	6.71e-06	0.000308	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—uterine cancer	6.6e-06	0.000303	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—uterine cancer	6.49e-06	0.000298	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C3—uterine cancer	6.24e-06	0.000287	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—uterine cancer	6.24e-06	0.000286	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMAD3—uterine cancer	6.12e-06	0.000281	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PGR—uterine cancer	6.08e-06	0.000279	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMAD3—uterine cancer	6.03e-06	0.000277	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—YWHAE—uterine cancer	5.8e-06	0.000266	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FBXW7—uterine cancer	5.56e-06	0.000255	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—uterine cancer	4.92e-06	0.000226	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STK11—uterine cancer	4.86e-06	0.000223	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOCS3—uterine cancer	4.55e-06	0.000209	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—uterine cancer	4.36e-06	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—uterine cancer	4.23e-06	0.000194	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMAD3—uterine cancer	3.98e-06	0.000183	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR2—uterine cancer	3.8e-06	0.000174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—uterine cancer	2.86e-06	0.000131	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—uterine cancer	2.38e-06	0.000109	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—uterine cancer	2.34e-06	0.000107	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—uterine cancer	2.26e-06	0.000104	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—uterine cancer	2.21e-06	0.000101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—uterine cancer	2.09e-06	9.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—uterine cancer	2.03e-06	9.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—uterine cancer	1.94e-06	8.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—uterine cancer	1.84e-06	8.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—uterine cancer	1.81e-06	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—uterine cancer	1.8e-06	8.27e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—uterine cancer	1.77e-06	8.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—uterine cancer	1.56e-06	7.17e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—uterine cancer	1.43e-06	6.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—uterine cancer	1.39e-06	6.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—uterine cancer	1.33e-06	6.09e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—uterine cancer	1.17e-06	5.38e-05	CbGpPWpGaD
